Frezza E E, Wachtel M S, Chiriva-Internati M
Department of Surgery, Division of General Surgery, Texas Tech University Health Sciences Center, MOP Building, Suite 380, 3502 9th St, Lubbock, Texas 79415, USA.
Gut. 2006 Feb;55(2):285-91. doi: 10.1136/gut.2005.073163. Epub 2005 Oct 20.
Obesity is a risk factor for many diseases. Thirty per cent of Americans are viewed as super obese; therefore, we need to find a solution. We already know about the diseases associated with obesity such as high blood pressure, diabetes, sleep apnoea, etc. Lately, there has been an increased interest in understanding if cancer is related to obesity. In this paper, we review the incidence of colon cancer and obesity. Insulin is the best established biochemical mediator between obesity and colon cancer. Hyperinsulinaemia, such as occurs in type II diabetes, is important in the pathogenesis of colon cancer. All adipose tissue is not equal. Visceral abdominal fat has been identified as the essential fat depot for pathogenetic theories that relate obesity and colon cancer. The genders differ as regards to how the relationship between obesity and colon cancer has been evaluated. Obesity imposes a greater risk of colon cancer for men of all ages and for premenopausal women than it does for postmenopausal women. Regular exercise reduces the risk of developing colon cancer and the risk of death from colon cancer should it develop. We believe that a combination of waist circumference (WC) and body mass index (BMI) measurements is recommended to assess the obesity related risk of developing colon cancer. Radiographic assessments of visceral abdominal fat may eventually prove to be the best means of assessing a patient's obesity related risk of developing colon cancer. Although WC is better established as a measure of obesity than BMI, the evidence for colon cancer risk is not secure on this point; combining BMI and WC measurements would appear, at present, to be the wisest approach for colon cancer risk assessment. Doctors who wish to decrease their patients' risk of dying of colon cancer should advise weight loss and exercise. Conversely, physicians and public health authorities should consider both exercise and obesity when designing colon cancer screening protocols. Morphometric cut offs should be adjusted, if possible, for age, sex, ethnicity, and height.
肥胖是许多疾病的危险因素。30%的美国人被视为超级肥胖;因此,我们需要找到一个解决方案。我们已经了解与肥胖相关的疾病,如高血压、糖尿病、睡眠呼吸暂停等。最近,人们对了解癌症是否与肥胖有关的兴趣有所增加。在本文中,我们回顾了结肠癌和肥胖的发病率。胰岛素是肥胖与结肠癌之间最确定的生化介质。高胰岛素血症,如在II型糖尿病中出现的情况,在结肠癌的发病机制中很重要。并非所有的脂肪组织都是一样的。内脏腹部脂肪已被确定为与肥胖和结肠癌相关的发病机制理论中的关键脂肪储存部位。在评估肥胖与结肠癌之间的关系方面,性别存在差异。肥胖对所有年龄段的男性和绝经前女性患结肠癌的风险比对绝经后女性的风险更大。经常锻炼可降低患结肠癌的风险,以及如果患结肠癌后的死亡风险。我们认为,建议结合腰围(WC)和体重指数(BMI)测量来评估与肥胖相关的患结肠癌风险。对内脏腹部脂肪的影像学评估最终可能被证明是评估患者与肥胖相关的患结肠癌风险的最佳方法。虽然WC作为肥胖的衡量指标比BMI更成熟,但在这一点上结肠癌风险的证据并不确凿;目前,结合BMI和WC测量似乎是评估结肠癌风险最明智的方法。希望降低患者死于结肠癌风险的医生应建议患者减肥和锻炼。相反,医生和公共卫生当局在设计结肠癌筛查方案时应考虑锻炼和肥胖因素。如果可能还应根据年龄、性别、种族和身高调整形态测量的临界值。